Abstract:Overall adiposity and body fat distribution are heritable traits associated with altered risk of cardiometabolic disease and mortality. Performing rare variant (minor allele frequency<1%) association testing using exome-sequencing data from 402,375 participants in the UK Biobank (UKB) for nine overall and tissue-specific fat distribution traits, we identified 19 genes where putatively damaging rare variation associated with at least one trait (Bonferroni-adjusted <1.58×10 ) and 52 additional genes at FDR≤1% ( ≤4.37×10 ). These 71 genes exhibited higher ( =3.58×10 ) common variant prioritisation scores than genes not significantly enriched for rare putatively damaging variation, with evidence of allelic series (dose-response relationships) among ultra-rare variants (minor allele count≤10) in 18 genes. Five of the 71 genes have cognate protein UKB Olink data available; all five associated ( <3.80×10 ) with three or more analysed traits. Combining rare and common variation evidence, allelic series and proteomics, we selected 17 genes for CRISPR knockout in human white adipose tissue cell lines. In three previously uncharacterised target genes, knockout increased (two-sided -test <0.05) lipid accumulation, a cellular phenotype relevant for fat mass traits, compared to Cas9-empty negative controls: (fold change [FC]=1.72, =0.0028), (FC=1.35, =0.0096), and (FC=1.39, =0.0157); furthermore, knockout of resulted in reduced lipid accumulation (FC=0.51, =1.91×10 ). Integrating across population-based genetic and functional evidence, we highlight therapeutic avenues for altering obesity and body fat distribution by modulating lipid accumulation.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to identify biological pathways that affect obesity and fat distribution by combining human genetic evidence and functional screening. Specifically, researchers used large - scale whole - exome sequencing data to conduct rare variant association tests on nine traits related to overall obesity and specific - tissue fat distribution in 402,375 participants from the UK Biobank. The aim was to discover genes significantly associated with these traits and further explore the biological effects of these genes at the cellular level, thereby providing potential targets for developing new methods to treat obesity or abnormal fat distribution. ### Main research questions: 1. **Identifying genes related to obesity and fat distribution**: Through rare variant (minor allele frequency < 1%) association tests, identify genes that are significantly associated with overall obesity and specific - tissue fat distribution traits. 2. **Evaluating combined evidence of common and rare variants**: Combine the evidence of rare and common variants to evaluate the priority of these genes in the population and look for possible dose - response relationships. 3. **Validating the biological function of genes**: Validate the function of these genes in human white adipose tissue cell lines through CRISPR - Cas9 knockout experiments, especially their impact on lipid accumulation. 4. **Exploring potential therapeutic targets**: Determine possible therapeutic targets for treating obesity or abnormal fat distribution by integrating multi - modal evidence (GWAS, ES, proteomics, and in vitro functional experiments). ### Research methods: - **Rare variant association test**: Use the SKAT - O method for gene - level rare variant association tests. - **Common variant priority scoring**: Evaluate the common variant priority score (Polygenic Priority Scores, PoPS) to determine the importance of genes. - **Proteomics analysis**: Evaluate the relationship between 1,463 plasma proteins and obesity and fat distribution traits. - **In vitro functional validation**: Validate the function of genes in human white adipose tissue cell lines through CRISPR - Cas9 knockout experiments. ### Main findings: - **19 genes identified**: Rare deleterious variants in these genes were significantly associated with BMI, body fat percentage, or waist - to - hip ratio (WHRadjBMI). - **52 additional genes**: Under a more liberal significance threshold (FDR ≤ 1%), 52 genes related to obesity or fat distribution traits were discovered. - **Dose - response relationships**: Dose - response relationships of ultra - rare variants (MAC ≤ 10) were observed in 22 genes. - **In vitro functional validation**: CRISPR - Cas9 knockout experiments were carried out in 17 genes. Among them, the knockout of 3 genes (COL5A3, EXOC7, TRIP10) increased lipid accumulation, while the knockout of SLTM decreased lipid accumulation. ### Conclusion: This study successfully identified multiple genes related to obesity and fat distribution by integrating evidence from genetics and functional experiments and verified the biological effects of these genes at the cellular level. These findings provide potential targets for developing new methods to treat obesity or abnormal fat distribution.

Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution

Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution

Identification and functional validation of rare coding variants in genes linked to monogenic obesity

Predicting novel candidate human obesity genes and their site of action by systematic functional screening in Drosophila

Genetic Evidence for Different Adiposity Phenotypes and Their Opposing Influences on Ectopic Fat and Risk of Cardiometabolic Disease

Severe obesity may be an oligogenic condition: evidence from 1,714 adults seeking treatment in the UK National Health Service

High-resolution genomic profiling and locus-specific FISH in subcutaneous and visceral adipose tissue of obese patients

Systems genetics analysis of human body fat distribution genes identifies adipocyte processes

Weighted burden analysis of rare coding variants in 470,000 exome-sequenced UK Biobank participants characterises effects on hyperlipidaemia risk

Rare variant associations with birth weight identify genes involved in adipose tissue regulation, placental function and insulin-like growth factor signalling

Systems genetics analysis of human body fat distribution genes identifies Wnt signaling and mitochondrial activity in adipocytes

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes

Single nucleus RNA-sequencing integrated into risk variant colocalization discovers 17 cell-type-specific abdominal obesity genes for metabolic dysfunction-associated steatotic liver disease

Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

Shared genetic loci for body fat storage and adipocyte lipolysis in humans

Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank

Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology

Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease

Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation

Common genetic variants associated with obesity in an African-American and Hispanic/Latino population

Identification of a 1p21 independent functional variant for abdominal obesity